Ticker	Volume	Price	Price Delta
DJIA	15,303.10	+8.60	0.06%
S&P 500	1,649.60	-0.91	-0.06%
Nasdaq	3,459.14	-0.27	-0.01%

Ticker

Volume

Price

Price Delta

DJIA

15,303.10

+8.60

0.06%

S&P 500

1,649.60

-0.91

-0.06%

Nasdaq

3,459.14

-0.27

-0.01%

Ticker	Volume	Price	Price Delta
STOXX 50	2,764.29	-12.49	-0.45%
FTSE 100	6,654.34	-42.45	-0.63%
DAX	8,305.32	-46.66	-0.56%

Ticker

Volume

Price

Price Delta

STOXX 50

2,764.29

-12.49

-0.45%

FTSE 100

6,654.34

-42.45

-0.63%

DAX

8,305.32

-46.66

-0.56%

Ticker	Volume	Price	Price Delta
Nikkei	14,612.50	+128.47	0.89%
Hang Seng	22,618.70	-51.01	-0.23%
S&P/ASX 200	4,983.50	-78.95	-1.56%

Ticker

Volume

Price

Price Delta

Nikkei

14,612.50

+128.47

0.89%

Hang Seng

22,618.70

-51.01

-0.23%

S&P/ASX 200

4,983.50

-78.95

-1.56%

Exchange: Frankfurt
Sector: Consumer, Non-cyclical
Industry: Biotechnology
Sub-Industry: Medical-Biomedical/Gene

Illumina Inc

+ Add to Watchlist

ILU:GR

53.837 EUR 0.563 1.03%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 05:41:16 ET on 05/24/2013.

Snapshot for Illumina Inc (ILU)

Open:	54.440	Day's Range:	53.837 - 54.440	Volume:	130
Previous Close:	54.400	52wk Range:	30.430 - 57.822	1-Yr Rtn:	+53.34%

Stock Chart for ILU

No chart data available.

ILU:GR 53.920

54.400

Interactive ILU Chart

…

Previous Close

Key Statistics for ILU

Current P/E Ratio (ttm)	-
Estimated P/E(12/2013)	41.5981
Relative P/E vs. DAX	-
Earnings Per Share (USD) (ttm)	-
Est. EPS (USD) (12/2013)	1.6720
Est. PEG Ratio	2.3791
Market Cap (M EUR)	0.00
Shares Outstanding (M)	0.00
30 Day Average Volume	335
Price/Book (mrq)	-
Price/Sale (ttm)	-
Dividend Indicated Gross Yield	-%
Cash Dividend	-
Last Dividend
5 Year Dividend Growth	-
Next Earnings Announcement	07/24/2013

mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILU

Revenue
Net Income (M/USD)

Profit Margin (%)

Company Profile & Key Executives for ILU

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.